Nintedanib Impurity 22 | CAS 2410284-89-6 - Request Quote
Nintedanib Impurity 22
| SZ CAT No: | SZ-N023033 |
| CAS No | 2410284-89-6 |
| Mol.F. | C22H30N6O2 |
| Mol.Wt. | 410.5 |
| Inv. Status | In Stock |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
CHNS Ratio (%) :
Usage Note:
Nintedanib Impurity 22 is chemically 2,2'-(piperazine-1,4-diyl)bis(N-(4-aminophenyl)-N-methylacetamide). Nintedanib Impurity 22 is supplied with detailed characterization data compliant with regulatory guideline. Nintedanib Impurity 22 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Nintedanib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 2410284-89-6
Purchase 2410284-89-6
Order 2410284-89-6
Enquire 2410284-89-6
price of 2410284-89-6
2410284-89-6 Supplier
2410284-89-6 Manufacturer
2410284-89-6 Exporter
buy high quality Nintedanib Impurity 22
Purchase Nintedanib Impurity 22
Nintedanib Impurity 22 suppliers
Nintedanib Impurity 22 manufacturers
Nintedanib Impurity 22 price
Order Nintedanib Impurity 22
Enquire Nintedanib Impurity 22
Nintedanib Impurity 22 cost
Nintedanib Impurity 22 Supplier
Nintedanib Impurity 22 Distributor
Nintedanib Impurity 22 for Method Validation
Nintedanib Reference Standard
Nintedanib Impurity 22 for ANDA Filing
Nintedanib Impurity 22 for Forced Degradation Studies
Nintedanib Impurity 22 Identification Standards
Nintedanib Impurity 22 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.